Cetera Investment Advisers’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-625
Closed -$14K 3811
2024
Q3
$14K Buy
625
+40
+7% +$811 ﹤0.01% 3659
2024
Q2
$13.9K Hold
585
﹤0.01% 3662
2024
Q1
$17.9K Buy
+585
New +$22.2K ﹤0.01% 3637
2022
Q2
Sell
-771
Closed -$90K 1850
2022
Q1
$90K Buy
771
+2
+0.3% +$331 ﹤0.01% 1811
2021
Q4
$199K Sell
769
-2
-0.3% -$608 ﹤0.01% 1741
2021
Q3
$211K Sell
771
-26
-3% -$7.5K ﹤0.01% 1635
2021
Q2
$341K Buy
+797
New +$303K 0.01% 1338

Other funds holding DRIO

Cetera Investment Advisers's DRIO Position: Q4 2024 in Review

Cetera Investment Advisers sold out of DarioHealth (DRIO) in Q4 2024, closing a stake of 625 shares — an estimated $14K sold.

Cetera Investment Advisers first reported a position in DRIO in Q2 2021 and held it in 7 quarters. The position peaked at $341K in Q2 2021. 40 funds tracked by Wall St. Rank hold DRIO as of Q4 2024.

  • Cetera Investment Advisers reported no remaining DarioHealth position as of Q4 2024 after selling out during the quarter.
  • Cetera Investment Advisers sold 625 DarioHealth shares in Q4 2024, an estimated $14K.
  • Cetera Investment Advisers first reported a position in DarioHealth in Q2 2021 and held it in 7 quarters.
  • Cetera Investment Advisers's DarioHealth position peaked at $341K in Q2 2021.
  • 40 funds tracked by Wall St. Rank held DarioHealth as of Q4 2024.

Based on Cetera Investment Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.